Insider Trading Activity - CRANDELL KEITH

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for CRANDELL KEITH

Goto 0, 1, 2, Next

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2022-10-24 Purchase	2022-10-26 8:01 pm	Prime Medicine Inc.	PRME	ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner	800,000	$17	$13,600,000	6,128,297 (Indirect)	View
2022-09-13 Purchase	2022-09-15 6:53 pm	Codiak BioSciences Inc.	CDAK	ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner	5,000,000	$1.5	$7,500,000	13,854,098 (Indirect Direct)	View
2021-08-12 Sale	2021-08-13 6:35 pm	Twist Bioscience Corp	TWST	CRANDELL KEITH Director	45,000	$107.01	$4,815,377	1,172,002 (Indirect Direct)	View
2021-07-30 Purchase	2021-08-03 9:12 pm	DA32 Life Science Tech Acquisition Corp.	DALS	CRANDELL KEITH Director 10% Owner	1,600,000	$10	$16,000,000	2,250,000 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2023-02-07 Option Award	2023-02-09 6:08 pm	N/A N/A	Twist Bioscience Corp	TWST	CRANDELL KEITH Director 10% Owner	8,212	$0	12,189 (Direct)	View
2023-01-03 Option Award	2023-01-04 4:03 pm	2023-12-31 2033-01-03	Quanterix Corp	QTRX	CRANDELL KEITH Director	20,207	$0	142,190 (Direct)	View
2023-01-03 Option Award	2023-01-04 4:03 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director	1,015	$12.86	142,190 (Direct)	View
2022-10-24 Conversion	2022-10-26 8:01 pm	N/A N/A	Prime Medicine Inc.	PRME	ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner	41,344,576	$0	6,128,297 (Indirect)	View
Ownership	2022-10-19 8:08 pm	N/A N/A	Prime Medicine Inc.	PRME	ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner	0	$0	11,456,594 (Indirect)	View
2022-10-03 Option Award	2022-10-05 4:04 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director	1,326	$10.48	120,968 (Direct)	View
2022-09-02 Other	2022-09-07 8:29 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,035,018	$0	1,126,748 (Indirect)	View
2022-08-30 Other	2022-09-01 5:20 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,035,006	$0	1,117,864 (Indirect)	View
2022-08-24 Other	2022-08-26 5:12 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,035,006	$0	1,109,010 (Indirect)	View
2022-08-18 Other	2022-08-22 5:14 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	517,503	$0	582,653 (Indirect)	View
2022-08-12 Other	2022-08-16 9:04 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,552,509	$0	1,613,232 (Indirect)	View
2022-07-01 Option Award	2022-07-06 4:07 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director 10% Owner	893	$16.79	119,642 (Direct)	View
2022-06-15 Exercise	2022-06-17 4:15 pm	N/A N/A	908 Devices Inc.	MASS	CRANDELL KEITH Director 10% Owner	1,379	$0	5,739,165 (Direct)	View
2022-06-16 Option Award	2022-06-17 4:15 pm	N/A N/A	908 Devices Inc.	MASS	CRANDELL KEITH Director 10% Owner	12,741	$0	5,739,165 (Direct)	View
2022-06-08 Other	2022-06-10 9:27 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	517,503	$0	564,945 (Indirect)	View
2022-06-02 Other	2022-06-06 8:24 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	517,502	$0	10,955,581 (Indirect)	View
2022-04-01 Option Award	2022-04-05 4:42 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director 10% Owner	492	$30.47	118,749 (Direct)	View
2022-02-08 Option Award	2022-02-10 7:32 pm	N/A N/A	Twist Bioscience Corp	TWST	CRANDELL KEITH Director	3,491	$0	80,024 (Direct)	View
2021-11-16 Other	2022-01-05 4:06 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director 10% Owner	619,520	$0	741,779 (Indirect)	View
2022-01-03 Option Award	2022-01-05 4:06 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director 10% Owner	307	$42.41	741,779 (Direct)	View
2022-01-03 Option Award	2022-01-05 4:06 pm	2022-12-31 2032-01-03	Quanterix Corp	QTRX	CRANDELL KEITH Director 10% Owner	6,670	$0	741,779 (Direct)	View
2021-12-20 Other	2021-12-22 5:59 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,811,207	$0	12,527,079 (Indirect)	View
2021-11-29 Other	2021-12-01 6:30 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	517,485	$0	12,205,620 (Indirect)	View
2021-11-22 Other	2021-11-24 5:58 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	517,485	$0	12,483,411 (Indirect)	View
2021-08-10 Other	2021-10-05 4:02 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director 10% Owner	639,906	$0	969,610 (Indirect)	View
2021-10-01 Option Award	2021-10-05 4:02 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director 10% Owner	254	$51.18	969,610 (Direct)	View
2021-02-11 Other	2021-08-13 6:35 pm	N/A N/A	Twist Bioscience Corp	TWST	CRANDELL KEITH Director	1,051,881	$0	1,172,002 (Indirect)	View
2021-08-05 Disposition	2021-08-09 8:35 pm	N/A N/A	DA32 Life Science Tech Acquisition Corp.	DALS	CRANDELL KEITH Director 10% Owner	701,250	$0	4,495,000 (Indirect)	View
2021-07-30 Option Award	2021-08-03 9:12 pm	N/A N/A	DA32 Life Science Tech Acquisition Corp.	DALS	CRANDELL KEITH Director 10% Owner	650,000	$10	2,250,000 (Indirect)	View
Ownership	2021-07-27 9:51 pm	N/A N/A	DA32 Life Science Tech Acquisition Corp.	DALS	CRANDELL KEITH Director 10% Owner	0	$0	5,196,250 (Direct)	View
2021-07-20 Conversion	2021-07-20 8:53 pm	N/A N/A	Erasca Inc.	ERAS	ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner	18,794,443	$0	5,527,777 (Indirect)	View
Ownership	2021-07-15 9:06 pm	N/A N/A	Erasca Inc.	ERAS	ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner	0	$0	11,055,554 (Indirect)	View
2021-07-01 Option Award	2021-07-06 5:17 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director	218	$59.48	1,634,632 (Direct)	View
2021-05-13 Other	2021-07-06 5:17 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director	1,083,710	$0	1,634,632 (Indirect)	View
2021-03-09 Other(A)	2021-07-06 5:17 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director	877,287	$0	1,803,061 (Indirect)	View
2021-04-01 Option Award(A)	2021-07-06 5:17 pm	N/A N/A	Quanterix Corp	QTRX	CRANDELL KEITH Director	211	$61.45	1,803,061 (Direct)	View
2021-07-01 Other	2021-07-06 4:47 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	4,033,412	$0	16,277,129 (Indirect)	View
2021-06-30 Other	2021-07-02 5:19 pm	N/A N/A	Beam Therapeutics Inc.	BEAM	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner	208,052	$0	3,357,682 (Indirect)	View
2021-06-25 Other	2021-06-29 5:22 pm	N/A N/A	Beam Therapeutics Inc.	BEAM	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner	416,104	$0	3,961,048 (Indirect)	View
2021-06-22 Other	2021-06-24 5:03 pm	N/A N/A	Vir Biotechnology Inc.	VIR	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	1,008,348	$0	15,501,684 (Indirect)	View
2021-06-21 Conversion	2021-06-23 5:42 pm	N/A N/A	Lyell Immunopharma Inc.	LYEL	ARCH Venture Partners IX LLC ARCH Venture Fund IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Partners IX L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	54,619,074	$0	18,206,358 (Indirect)	View
2021-06-21 Conversion	2021-06-23 4:29 pm	N/A N/A	Verve Therapeutics Inc.	VERV	ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner	25,739,146	$0	1,254,405 (Indirect)	View
2021-06-17 Option Award	2021-06-21 08:07 am	N/A 2031-06-17	908 Devices Inc.	MASS	CRANDELL KEITH Director 10% Owner	3,834	$0	3,834 (Direct)	View
Ownership	2021-06-16 9:00 pm	N/A N/A	Lyell Immunopharma Inc.	LYEL	ARCH Venture Partners IX LLC ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Partners IX L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner	0	$0	36,412,716 (Indirect)	View
Ownership	2021-06-16 7:35 pm	N/A N/A	Verve Therapeutics Inc.	VERV	ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners X LLC CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner	0	$0	2,508,809 (Indirect)	View
2021-04-13 Other	2021-04-15 5:18 pm	N/A N/A	Karuna Therapeutics Inc.	KRTX	ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. BYBEE CLINTON CRANDELL KEITH 10% Owner	76,264	$0	1,608,617 (Indirect)	View

(A) Indicate amendment filing.

Goto 0, 1, 2, Next

Insider Trading & Ownership - CRANDELL KEITH